HSF1 and neoplasm: Notably, there was an increased tendency toward severe tumor damage induced by mEHT in the mEHT-treated HSF1-KO group (mEHT EV: 74.6 ± 11%; mEHT HSF1-KO: 84.1 ± 10.6%, p = 0.52, ns).